News cer declined 12% over the same period, when millions of women stopped taking HRT
after the release of a July 2002 Women's Health Initiative study indicating HRT bore more …

This issue contains two important papers' J on the controversial issue of the management of
climacteric after the diagnosis and treatment of breast cancer. Whether hormone …

1140 Editorials| JNCI Vol. 99, Issue 15| August 1, 2007 than a fraction of the drop. Another
possibility is tamoxifen/raloxifene, but their use was nearly constant before and during this …

The recent, sudden declines in breast cancer incidence in the United States (1, 2) are
unprecedented, and their origins are of great relevance to breast cancer prevention. To date …

In 2003, breast cancer incidence in the United States dropped sharply, and this decline may
be due to the fact that millions of older women stopped using HT in 2002. Investigators from …

Background: The publication of the Women's Health Initiative Study in 2002 spurred
reductions in hormone replacement therapy (HRT) use worldwide. Subsequent drops in …

Goss presented preliminary analysis of results from a study of the effects of receiving HRT at
and before diagnosis on the clinical presentation of breast cancer and on the biology of the …

The incidence of breast cancer in the US dropped sharply between 2002 and 2003. In this
Viewpoint, the author discusses two theories to account for this observation: the decrease in …

I was delighted to accept this invitation from the The Breast, to write this editorial out of
sympathy for the countless women who have arrived at my clinic frightened by the scare …

The authors say that their findings raise several new questions: How long will the effect last?
Have the tumors stopped or just slowed? And what are the characteristics of those tumors …